Close Menu

NEW YORK – Immune prognostic tools developer PredictImmune announced Monday an exclusive partnership for diagnostic company Theradiag to promote, license, and distribute the PredictSure IBD test in French-speaking countries in Europe and Africa.

France-based Theradiag, which specializes in in vitro diagnostics and theranostics for autoimmune disease, will lead commercialization in France, Belgium, Luxembourg, Switzerland, and the Maghreb countries in northwest Africa.

Other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.